iSTAR releases follow-up data for MINIject glaucoma implant
The glaucoma surgery device market is expected to grow to be worth $345m in the US by 2030. Image Credit: Guzaliia Filimonova / Getty Images. iSTAR Medical has released three-year follow-up data of the MINIject glaucoma implant to treat patients with open-angle glaucoma uncontrolled by topical hypotensive medications. Open-angle glaucoma is chronic, progressive, and irreversible […]
Biological Dynamics and PRECEDE partner for cancer surveillance
The partnership will conduct patient surveillance for early pancreatic cancer using Biological Dynamics’ ExoVita Pancreas Assay. Credit: Nemes Laszlo / Shutterstock.com. Biological Dynamics has signed a multi-year agreement with the Pancreatic Cancer Early Detection (PRECEDE) Consortium to improve the surveillance of early pancreatic cancer. Leveraging Biological Dynamics’ ExoVita Pancreas Assay, powered by the Verita platform, […]
Laborie agrees to acquire Urotronic in $600m deal
Urotronic’s drug-coated balloon technology is utilised in interventional urology. Credit: Pixel-Shot / Shutterstock.com. Laborie Medical Technologies has entered a definitive agreement for the acquisition of medical device company Urotronic in a deal valued at up to $600m. As per the deal, Laborie will make an upfront cash payment of $255m to Urotronic. Urotronic is entitled […]
Exactech introduces TriVerse for knee replacement patients
Exactech’s TriVerse primary knee system. Credit: Exactech. Exactech has unveiled TriVerse, a new primary knee system that has treated its first cases of active knee replacement patients. This implant has anterior and posterior stabilised components and is completely made of well-crosslinked vitamin E polyethylene. Featuring intraoperative flexibility and simplicity, TriVerse allows for same-day surgical procedures […]
Synchron completes enrolment in neural interface technology trial
Synchron’s BCI will be implanted into six patients with quadriparesis. Credit: Piscine26 via Shutterstock. US-based endovascular company Synchron has completed patient enrolment in its brain-computer interface (BCI) clinical trial. The company is developing implantable neural interface technology for people with severe motor impairment. The goal of the trial is to assess if the Synchron Switch […]
Abbott signs definitive agreement to acquire Bigfoot Biomedical
Abbott and Bigfoot Biomedical have worked together on connected diabetes solutions. Credit: Michael We/Shutterstock.com. Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a […]
Eko Health and FIGS partner to launch new digital stethoscope
The FIGS | Eko CORE 500 Digital Stethoscope features a full-colour screen that displays heart rate and electrocardiogram monitoring. Credit: Eko Health. Eko Health and FIGS have forged a partnership to unveil the new FIGS | Eko CORE 500 Digital Stethoscope. The new offering combines the US Food and Drug Administration (FDA)-approved CORE 500 Digital […]
AstraZeneca hopes to make clinical trial operations carbon-negative by 2030
AstraZeneca has spoken about how they are delivering ambitious plans to help other pharma companies follow suit. Image credit: AstraZeneca. AstraZeneca has big plans to become carbon-negative by 2030, including collecting human samples obtained in clinical trials. The company is working with its collaborators, including sites and suppliers to ensure the entire chain footprint is […]
Ibex lands $55m in Series C funding
Ibex’s cancer diagnostic platform, Galen uses AI workflows and decision support tools to assist pathologists with manual work and visual analysis of biopsies. Credit: Ibex Medical Analytics Israel-based cancer diagnostics firm Ibex Medical Analytics has announced the close of a Series C financing round, accumulating a total of $55 million in funds and bringing its […]
FDA authorise Xenex LightStrike+ UV Robot
The latest FDA authorisation has created a new medical device classification, with LightStrike+ being the first device to receive this label. Ultraviolet (UV) disinfecting solution provider, Xenex Disinfection Services has been granted De Novo authorisation from the US Food & Drug Administration (FDA) for its UV robot LightStrike+. The latest authorisation has created a new […]